A Phase 1a/1b Open-label, Dose-Escalation and Expansion Study of TPST-1495 as a Single Agent and in Combination with Pembrolizumab in Subjects with Solid Tumors

This Study is
No Longer Enrolling

Details
Age

Adult

Type of Study

Treatment

Locations

CTRC Inpatient
University of Colorado Hospital

Study ID

Protocol Number: 23-0504

More information available at ClinicalTrials.gov: NCT04344795

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers